Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma

被引:0
作者
Chen, Zhi [1 ]
Li, Zuan [1 ]
Li, Chunlin [1 ]
Li, Bingcai [1 ]
Wang, Haojian [1 ]
Nong, Deyong [1 ]
Li, Ximing [1 ]
Huang, Guihai [1 ]
Lin, Junhao [1 ]
Li, Wei [1 ]
机构
[1] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Urol, Nanning, Peoples R China
基金
中国国家自然科学基金;
关键词
Renal cell carcinoma; Speckle-type POZ protein; In vitro proliferation; Migration; Invasion; Apoptosis; TUMOR-SUPPRESSOR GENE; SIGNALING PATHWAY; SPOP; CANCER; PROSTATE; TUMORIGENESIS; ACTIVATION; EXPRESSION; RELEVANCE; ADJACENT;
D O I
10.1186/s12885-022-10340-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Speckle-type POZ protein(SPOP), a substrate adaptor of Cul3 ubiquitin ligase, plays crucial roles in solid neoplasms by promoting the ubiquitination and degradation of substrates. Limited studies have shown that SPOP is overexpressed in human renal cell carcinoma (RCC) tissue. However, the exact role of SPOP in RCC remains unclear and needs to be further elucidated. The present study showed that SPOP was expressed at different levels in different RCC cell lines. The purpose of this study was to explore the roles of SPOP in the biological features of RCC cells and the expression levels of SPOP in human tissue microarray (TMA) and kidney tissues. Methods: Here, SPOP was overexpressed by lentiviral vector transfection in ACHN and Caki-1 cells, and SPOP was knocked down in Caki-2 cells with similar transfection methods. The transfection efficiency was evaluated by quantitative PCR and western blotting analyses. The role of SPOP in the proliferation, migration, invasion and apoptosis of cell lines was determined by the MTT, wound-healing, transwell and flow cytometry assays. Moreover, the cells were treated with different drug concentrations in proliferation and apoptosis assays to investigate the effect of sunitinib and IFN-alpha 2b on the proliferation and apoptosis of SPOP-overexpressing cells and SPOP-knockdown RCC cells. Finally, immunohistochemical staining of SPOP was performed in kidney tissues and TMAs, which included RCC tissues and corresponding adjacent normal tissues. Results: Overexpression of SPOP inhibited cell proliferation, migration and invasion and increased cell apoptosis. Interestingly, sunitinib and IFN-alpha 2b at several concentrations increased the proliferation inhibitory rate and total apoptosis rate of cells overexpressing SPOP. The findings of the present study showed that the SPOP protein was significantly expressed at low levels in most clear cell RCC (ccRCC) tissues and at relatively high levels in the majority of adjacent normal tissues and kidney tissues. Kaplan-Meier survival analysis showed that there was no statistically significant difference in cumulative survival based on the data of different SPOP expression levels in TMA and patients. Conclusions: In contrast to previous studies, our findings demonstrated that overexpression of SPOP might suppress the progression of RCC cells, which was supported by cell experiments and immunohistochemical staining. SPOP could be a potential tumour inhibitor in RCC.
引用
收藏
页数:11
相关论文
共 55 条
  • [1] Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome
    Arai, Eri
    Ushijima, Saori
    Fujimoto, Hiroyuki
    Hosoda, Fumie
    Shibata, Tatsuhiro
    Kondo, Tadashi
    Yokoi, Sana
    Imoto, Issei
    Inazawa, Johji
    Hirohashi, Setsuo
    Kanai, Yae
    [J]. CARCINOGENESIS, 2009, 30 (02) : 214 - 221
  • [2] SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence
    Atschekzei, Faranaz
    Hennenlotter, Joerg
    Jaenisch, Stefanie
    Grosshennig, Anika
    Traenkenschuh, Wolfgang
    Waalkes, Sandra
    Peters, Inga
    Doerk, Thilo
    Merseburger, Axel S.
    Stenzl, Arnulf
    Kuczyk, Markus A.
    Serth, Juergen
    [J]. EPIGENETICS, 2012, 7 (05) : 447 - 457
  • [3] Aufderklamm S, 2016, ANTICANCER RES, V36, P2865
  • [4] SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling
    Blattner, Mirjam
    Liu, Deli
    Robinson, Brian D.
    Huang, Dennis
    Poliakov, Anton
    Gao, Dong
    Nataraj, Srilakshmi
    Deonarine, Lesa D.
    Augello, Michael A.
    Sailer, Verena
    Ponnala, Lalit
    Ittmann, Michael
    Chinnaiyan, Arul M.
    Sboner, Andrea
    Chen, Yu
    Rubin, Mark A.
    Barbieri, Christopher E.
    [J]. CANCER CELL, 2017, 31 (03) : 436 - 451
  • [5] Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma
    Cardenas, Luisa M.
    Deluce, Jasna E.
    Khan, Shahrukh
    Gulam, Omar
    Vareki, Saman Maleki
    Fernandes, Ricardo
    Lalani, Aly-Khan A.
    [J]. CURRENT ONCOLOGY, 2022, 29 (08) : 5426 - 5441
  • [6] Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic implications
    Chen, Hsin-Yi
    Chen, Ruey-Hwa
    [J]. FRONTIERS IN ONCOLOGY, 2016, 6
  • [7] SPOP suppresses osteosarcoma invasion via PI3K/AKT/NF-κB signaling pathway
    Chen, L.
    Pei, H.
    Lu, S. -J.
    Liu, Z. -J.
    Yan, L.
    Zhao, X. -M.
    Hu, B.
    Lu, H. -G.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (03) : 609 - 615
  • [8] Chunyan Zeng YW., 2014, J EXP CLIN CANC RES, V33, P75, DOI [10.1186/s13046-014-0075-8, DOI 10.1186/S13046-014-0075-8]
  • [9] Hedgehog signaling inhibitors in solid and hematological cancers
    Cortes, Jorge E.
    Gutzmer, Ralf
    Kieran, Mark W.
    Solomon, James A.
    [J]. CANCER TREATMENT REVIEWS, 2019, 76 : 41 - 50
  • [10] The ubiquitin ligase adaptor SPOP in cancer
    Cuneo, Matthew J.
    Mittag, Tanja
    [J]. FEBS JOURNAL, 2019, 286 (20) : 3946 - 3958